Cardialysis B.V. deploys Heartlab's CardioNow

Heartlab will implement its CardioNow telecardiology and image management system for cardiovascular drug and device studies at Cardialysis B.V., a cardiology contract research organization in Rotterdam, The Netherlands.
           
With the technology, Cardialysis B.V. clients can use the web-based system to handle receipt, tracking, archiving, and analysis of complex cardiac images from hospital investigator sites around the world.
           
Heartlab's web-based CardioNow technology enables electronic sharing of patient angiograms and ultrasound studies required by cardiovascular device and drug clinical trials. Within minutes of patient enrollment, complete DICOM studies can be transferred from investigator sites to angiographic and ultrasound core worldwide labs, Heartlab said.
           
Additionally, these studies can be made available online for simultaneous review by other parties, such as clinical event committee members, safety monitoring board members and trial sponsors.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.